JANUS HENDERSON GROUP PLC – Alnylam Pharmaceuticals, Inc. Transaction History
JANUS HENDERSON GROUP PLC portfolio value:
$114.98M
portfolio value
JANUS HENDERSON GROUP PLC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +27.75% | 124.79K shares | 49.39M | $200.16 | 574.50K |
| Q2 2022 | share | Decrease | -24.85% | -148.73K shares | -32.13M | $145.85 | 449.71K |
| Q1 2022 | share | Increase | +19.37% | 97.11K shares | 12.7M | $163.29 | 598.44K |
| Q4 2021 | share | Increase | +2223.46% | 479.75K shares | 80.94M | $171.03 | 501.33K |
| Q3 2021 | share | Increase | +84.03% | 9.85K shares | 2.08M | $188.81 | 21.57K |
| Q2 2021 | share | Decrease | -35.52% | -6.45K shares | -580K | $169.52 | 11.72K |
| Q1 2021 | share | Decrease | -79.85% | -72.07K shares | -9.16M | $141.19 | 18.18K |
| Q4 2020 | share | Decrease | -44.48% | -72.31K shares | -11.93M | $129.97 | 90.25K |
| Q3 2020 | share | Decrease | -27.31% | -61.09K shares | -9.45M | $145.6 | 162.56K |
| Q2 2020 | share | Decrease | -45.11% | -183.79K shares | -11.22M | $148.11 | 223.66K |
| Q1 2020 | share | Increase | +661.93% | 353.98K shares | 38.19M | $108.85 | 407.45K |
| Q4 2019 | share | Increase | +31.91% | 12.93K shares | 2.89M | $115.17 | 53.47K |
| Q3 2019 | share | Increase | +51.54% | 13.78K shares | 1.31M | $80.42 | 40.53K |
| Q2 2019 | share | Increase | +5.97% | 1.50K shares | -418K | $72.56 | 26.75K |
| Q1 2019 | share | Increase | +3.45% | 841 shares | 581K | $93.45 | 25.24K |
| Q4 2018 | share | Decrease | -4.69% | -1.2K shares | -462K | $72.91 | 24.40K |
| Q3 2018 | share | Decrease | -75.02% | -76.9K shares | -7.85M | $87.52 | 25.60K |
| Q2 2018 | share | Decrease | -79.67% | -401.80K shares | -49.96M | $98.49 | 102.50K |
| Q1 2018 | share | Increase | +2.17% | 10.69K shares | -2.65M | $119.1 | 504.31K |
| Q4 2017 | share | Decrease | -27.73% | -189.40K shares | -17.53M | $127.05 | 493.61K |
| Q3 2017 | share | Increase | +2.35% | 15.68K shares | 27.02M | $117.49 | 683.02K |
| Q2 2017 | share | Increase | 0.00% | 667.33K shares | 53.22M | $79.76 | 667.33K |
| Q1 2017 | share | Decrease | -100.00% | -3.87K shares | -145K | $51.25 | 0 |
| Q4 2016 | share | Decrease | -61.74% | -6.25K shares | -542K | $37.44 | 3.87K |
| Q3 2016 | share | 0.00% | 0 shares | 125K | $67.78 | 10.13K | |
| Q2 2016 | share | 0.00% | 0 shares | -74K | $55.49 | 10.13K | |
| Q1 2016 | share | 0.00% | 0 shares | -319K | $62.77 | 10.13K |